Europe's Choice
Geopolitical shifts are reshaping life sciences. Europe can build on its strengths and lead or stand still and fall behind. What will it choose?
LEARN MOREHow can we ensure Europeans don't miss out on the latest advances in treatment?
EFPIA is asking EU leaders to work together with industry to create opportunities to, once again, make the region a world-leader in life sciences
EFPIA Code of Practice and relationships with patient organisations and healthcare professionals.
Latest Updates
VIEW ALL-
Statements & press releases 09.02.26
Digital Medicines Information gains momentum
A new report from AESGP, EFPIA and Medicines for Europe provides a comprehensive overview of electronic Product Information (ePI) pilot projects across...
Read Article -
Statements & press releases 09.02.26
European pharmaceuticals key to strengthening EU competitiveness
Without the pharmaceutical industry the EU trade balance would go from a surplus of €147 billion to a €47 billion deficit
Read Article -
Blog articles 04.02.26
More people are living with cancer for longer – and more young people are surviving it (Guest blog)
Across Europe, cancer care has been undergoing a slow but steady revolution. While the number of people diagnosed with cancer continues to rise, mortality...
Read Article -
External Event 10.03.26
2nd European Summit for Women Leaders in Life Sciences
Get ready for C5’s 2nd Annual European Summit for Women Leaders in Life Sciences Law — two days of impactful discussions, diverse perspectives, and meaningful...
View Event -
External Event 19.03.26
J&J | The essentials of partnering with a pharma company
Discover what it takes to build successful collaborations with pharmaceutical companies and accelerate your innovation to patients.
View Event -
External Event 24.03.26
DIA Europe 2026
Join the DIA Europe 2026 in March to explore how Europe can bring and keep innovation into the system to deliver better outcomes for patients.
View Event